Anticomplement activity of terpenoids from the spores of Ganoderma lucidum

Planta Med. 2001 Dec;67(9):811-4. doi: 10.1055/s-2001-18854.

Abstract

A new lanostane-type terpenoid, lucidenic acid SP1 (1), was isolated from a CHCl(3)-soluble fraction of Ganoderma lucidum spores together with four other known compounds (2 - 5). The structure of lucidenic acid SP1 was determined to be 3 beta,7 beta-dihydroxy-4,4,14 alpha-trimethyl-11,15-dioxo-5 alpha-chol-8-en-24-oic acid by spectroscopic means including 2D-NMR. Twelve triterpenes (1-12) isolated from G. lucidum spores were investigated in vitro for their anticomplementary activity. Compounds 1 - 5 were inactive, whereas ganoderiol F (8), ganodermanondiol (9) and ganodermanontriol (10) showed a strong anticomplement activity against the classical pathway (CP) of the complement system with IC(50) values of 4.8, 41.7, and 17.2 microM, respectively. The potency of these triterpene alcohols (8-10) in inhibiting CP activity was improved when the number of hydroxymethyl groups on the side chain moiety is increased. On the other hand, the ganoderic acids 1-7, which contain a carboxyl group in the side chain, and lucidumols A and B (11, 12) had little activity on this system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Complement Activation / drug effects
  • Complement Inactivator Proteins / chemistry
  • Complement Inactivator Proteins / pharmacology*
  • Drugs, Chinese Herbal
  • Hemolysis / drug effects
  • Hemolysis / immunology
  • Humans
  • Lanosterol / analogs & derivatives
  • Lanosterol / chemistry
  • Lanosterol / isolation & purification*
  • Lanosterol / pharmacology
  • Magnetic Resonance Spectroscopy
  • Reishi*
  • Stereoisomerism
  • Triterpenes / chemistry
  • Triterpenes / isolation & purification*
  • Triterpenes / pharmacology

Substances

  • 3,7-dihydroxy-4,4,14-trimethyl-11,15-dioxochol-8-en-24-oic acid
  • Complement Inactivator Proteins
  • Drugs, Chinese Herbal
  • Triterpenes
  • Lanosterol